Azadeh Golipour, Ph.D. - Publications

2013 Molecular and Medical Genetics University of Toronto, Toronto, ON, Canada 
Genetics, Molecular Biology, Cell Biology, Oncology

4/7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Han H, Irimia M, Ross PJ, Sung HK, Alipanahi B, David L, Golipour A, Gabut M, Michael IP, Nachman EN, Wang E, Trcka D, Thompson T, O'Hanlon D, Slobodeniuc V, et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature. 498: 241-5. PMID 23739326 DOI: 10.1038/nature12270  0.48
2012 Golipour A, David L, Liu Y, Jayakumaran G, Hirsch CL, Trcka D, Wrana JL. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell. 11: 769-82. PMID 23217423 DOI: 10.1016/j.stem.2012.11.008  0.48
2011 David L, Samavarchi-Tehrani P, Golipour A, Wrana JL. Looking into the black box: insights into the mechanisms of somatic cell reprogramming. Genes. 2: 81-106. PMID 24710139 DOI: 10.3390/genes2010081  0.48
2010 Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 7: 64-77. PMID 20621051 DOI: 10.1016/j.stem.2010.04.015  0.48
Low-probability matches
2008 Golipour A, Myers D, Seagroves T, Murphy D, Evan GI, Donoghue DJ, Moorehead RA, Porter LA. The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis. Cancer Research. 68: 3591-600. PMID 18483240 DOI: 10.1158/0008-5472.CAN-07-6453  0.28
2021 Dahl M, Smith EMK, Warsi S, Rothe M, Ferraz MJ, Aerts JMFG, Golipour A, Harper C, Pfeifer R, Pizzurro D, Schambach A, Mason C, Karlsson S. Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector. Molecular Therapy. Methods & Clinical Development. 20: 312-323. PMID 33511245 DOI: 10.1016/j.omtm.2020.11.018  0.01
2020 Volck B, Fallet S, Thomas M, Carnley B, Golipour A, Phillips D, Mason C. AVR-RD-01 lentiviral gene therapy reduces Gb3 substrate in endothelial cells of renal peritubular capillaries in a previously untreated classic Fabry disease male patient Molecular Genetics and Metabolism. 129: S156-S157. DOI: 10.1016/j.ymgme.2019.11.416  0.01
Hide low-probability matches.